-
The Cabinet of Ministers has increased the list of vital drugs
20 Jan 2025 12:57 GMT
… inclisiran, biapenem, atazanavir+ ritonavir, fampridine, glycopyrronium bromide+indacaterol+ mometasone, beclomethasone … the list of drugs for the treatment of patients with … drug izatuximab, used in the treatment of multiple myeloma.
50% of these medicines …
-
MS Drug Boosts Working Memory in Healthy Individuals
20 Nov 2024 06:22 GMT
Fampridine, a drug used to improve walking … the way for potential new treatments for schizophrenia and depression. The … analyses also show that the drug acts on certain ion channels … controlled crossover trial with 43 healthy young adults to assess fampridine’s …
-
Multiple sclerosis drug may help with poor working memory
19 Nov 2024 05:01 GMT
… to organize their thoughts.
Fampridine is a drug that could help in … . But it could be a treatment option for those with reduced … starting points for repurposing established drugs. Fampridine acts on specific ion channels …
-
Repurposed Multiple Sclerosis Drug May Improve Memory
18 Nov 2024 23:27 GMT
… making it a potential treatment for conditions involving cognitive … .
Researchers are planning trials to test its effectiveness … points for repurposing established drugs.
Fampridine acts on specific … fampridine on working memory: A randomized controlled trial …
-
Drug for Multiple Sclerosis Treatment May Help Poor Working Memory
18 Nov 2024 16:13 GMT
… . But it could be a treatment option for those with reduced … starting points for repurposing established drugs. Fampridine acts on specific ion channels … effect of fampridine on working memory: a randomized controlled trial based on …
-
Economic Evaluations of MS Treatments Across Global Cost-Effectiveness Studies
11 Nov 2024 15:24 GMT
… ), selection of benchmark treatments, data extrapolation beyond trial timeframes, and model time … horizons. Dimethyl fumarate (DMF) and fampridine …
-
Human medicines European public assessment report (EPAR): Fampyra, fampridine, Date of authorisation: 20/07/2011, Revision: 17, Status: Authorised
07 Oct 2024 18:38 GMT
Two main studies in 540 patients with multiple sclerosis showed that Fampyra was more effective than placebo (a dummy treatment) at improving walking speed. The patients were treated for 9 or 14 weeks, with their waking speed measured along a 25 feet (7.5 …
-
Human medicines European public assessment report (EPAR): Fampridine Accord, fampridine, Date of authorisation: 24/09/2020, Revision: 2, Status: Authorised
11 Apr 2024 11:43 GMT
For the body’s muscles to contract, electrical impulses are transmitted along the nerves to the muscles. In MS, this transmission of electrical impulses is impaired when the covering around the nerves become damaged, which can lead to muscle weakness, …
-
Acorda loses Nasdaq listing to cap biotech’s end
16 Apr 2024 16:27 GMT
… the twilight zone. The biotech’s closure date is set … Acorda saw success with its drugs for neurological disorders. Inbrija ( … ) — also marketed as Fampyra (fampridine) outside of the US — were … is the parent company of Pharmaceutical Technology.
Access the most …
-
Patient's anger as hundreds miss out on medication
15 Feb 2024 08:17 GMT
… the road,” she said.
Despite fampridine being approved more than four … offer it, despite new medicines generally being offered within 60 … 500 patients eligible for this treatment in its area.
Ms … relation to the introduction of fampridine in our health board …